These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 6831452
1. Accelerated progression to autonomy of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by hormones. Matsuzawa A, Kaneko T, Ikeda Y. Cancer Res; 1983 May; 43(5):2283-9. PubMed ID: 6831452 [Abstract] [Full Text] [Related]
2. Cytoplasmic estrogen receptor in a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous lines. Matsuzawa A, Mizuno Y, Yamamoto T, Hori T, Suzuki T. Cancer Res; 1980 Sep; 40(9):3361-8. PubMed ID: 7427949 [Abstract] [Full Text] [Related]
3. Differential response of an ovarian-responsive mouse mammary tumor to androgenic and estrogenic agents. Matsuzawa A, Ikeda Y. Cancer Res; 1983 Aug; 43(8):3680-6. PubMed ID: 6861137 [Abstract] [Full Text] [Related]
4. Pregnancy-dependent to ovarian-independent progression in mammary tumors delineated in primary culture: changes in signal transduction, growth factor regulation, and matrix interaction. Imagawa W, Bandyopadhyay GK, Garcia M, Matsuzawa A, Nandi S. Cancer Res; 1992 Dec 01; 52(23):6531-8. PubMed ID: 1330295 [Abstract] [Full Text] [Related]
5. Inhibited growth in vivo of a mouse pregnancy-dependent mammary tumor (TPDMT-4) by an antiestrogen, 2alpha, 3alpha-epithio-5alpha-androstan-17beta-ol (10275-S). Matsuzawa A, Yamamoto T. Cancer Res; 1976 May 01; 36(5):1598-606. PubMed ID: 178425 [Abstract] [Full Text] [Related]
6. Formation of duct-alveolar structures and new types of tumors by a pregnancy-dependent mouse mammary tumor (TPDMT-4) in virgin mice. Matsuzawa A, Kaneko T, Ikeda Y, Yamamoto T. Gan; 1982 Jun 01; 73(3):372-6. PubMed ID: 7129002 [Abstract] [Full Text] [Related]
7. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors. Bustuoabad OD, di Gianni PD, Franco M, Kordon EC, Vanzulli SI, Meiss RP, Grion LC, Díaz GS, Nosetto SH, Hockl P, Lombardi MG, Pasqualini CD, Ruggiero RA. Oncol Res; 2002 Jun 01; 13(3):147-60. PubMed ID: 12549624 [Abstract] [Full Text] [Related]
8. Comparative studies on estrogen receptors between a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous tumors. Matsuzawa A, Hayakawa T, Takitani S, Iwaguchi T. Endocrinology; 1987 Jun 01; 120(6):2346-56. PubMed ID: 3569134 [Abstract] [Full Text] [Related]
9. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins. Lanari C, Lüthy I, Lamb CA, Fabris V, Pagano E, Helguero LA, Sanjuan N, Merani S, Molinolo AA. Cancer Res; 2001 Jan 01; 61(1):293-302. PubMed ID: 11196177 [Abstract] [Full Text] [Related]
10. Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors. Kiss R, de Launoit Y, Danguy A, Paridaens R, Pasteels JL. Cancer Res; 1989 Jun 01; 49(11):2945-51. PubMed ID: 2720654 [Abstract] [Full Text] [Related]
12. Association of hst gene expression with metastatic phenotype in mouse mammary tumors. Murakami A, Tanaka H, Matsuzawa A. Cell Growth Differ; 1990 May 01; 1(5):225-31. PubMed ID: 1964796 [Abstract] [Full Text] [Related]
13. Antitumor effect of two oral steroids, mepitiostane and fluoxymesterone, on a pregnancy-dependent mouse mammary tumor (TPDMT-4). Matsuzawa A, Yamamoto T. Cancer Res; 1977 Dec 01; 37(12):4408-15. PubMed ID: 922732 [Abstract] [Full Text] [Related]
14. Progression of pregnancy-dependent mouse mammary tumors after long dormancy periods. Involvement of Wnt pathway activation. Gattelli A, Cirio MC, Quaglino A, Schere-Levy C, Martinez N, Binaghi M, Meiss RP, Castilla LH, Kordon EC. Cancer Res; 2004 Aug 01; 64(15):5193-9. PubMed ID: 15289324 [Abstract] [Full Text] [Related]
15. Response of a pregnancy-dependent mouse mammary tumor to hormones. Matsuzawa A, Yamamoto T. J Natl Cancer Inst; 1975 Aug 01; 55(2):447-53. PubMed ID: 1159826 [Abstract] [Full Text] [Related]
16. Hormonal control of growth and progression in tumors of Nb rats and a theory of action. Noble RL. Cancer Res; 1977 Jan 01; 37(1):82-94. PubMed ID: 830424 [Abstract] [Full Text] [Related]
17. Comparison of estrogen receptors in hormone-dependent and hormone-independent Grunder strain mouse mammary tumors. Moncharmont B, Ramp G, De Goeij CC, Sluyser M. Cancer Res; 1991 Aug 01; 51(15):3843-8. PubMed ID: 1855202 [Abstract] [Full Text] [Related]
18. Metallothionein expression in transplantable mouse mammary tumors. Yamamura Y, Sayama K, Takeda Y, Matsuzawa A, Iguchi T, Ohta Y. Anticancer Res; 2000 Aug 01; 20(1A):379-84. PubMed ID: 10769683 [Abstract] [Full Text] [Related]
19. Characterization of a slow-growing, transplantable rat mammary tumor (MCR-83): a model for endocrine-related cell kinetic studies. van Dierendonck JH, Cornelisse CJ, van der Linden PW, van Putten LM, van de Velde CJ. Cancer Res; 1987 Aug 01; 47(15):4093-8. PubMed ID: 3607751 [Abstract] [Full Text] [Related]
20. Antitumor effect of the antiestrogen, tamoxifen, ona pregnancy-dependent mouse mammary tumor (TPDMT-4). Matsuzawa A, Mizuno Y, Yamamoto T. Cancer Res; 1981 Jan 01; 41(1):316-24. PubMed ID: 7448771 [Abstract] [Full Text] [Related] Page: [Next] [New Search]